Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCA for Hypoglycemia-induced Brain Injury in T1DM
NCT03356457Phase 1Completed
- Sponsor
- Yale University
- Start
- Nov 2017
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dichloroacetate in type 1 diabetes mellitus (T1D) and hypoglycemia (4 arms), sponsored by Yale University. Primary endpoint: Measurement of hormone changes during hypoglycemia at 1 day. Started Nov 2017; status: completed.
02
Drugs
dichloroacetate
03
Conditions
type 1 diabetes mellitus (T1D)hypoglycemia
Beyond the preview
Go deeper on NCT03356457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03356457.